Building pathway clusters from Random Forests classification using class votes
暂无分享,去创建一个
[1] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[2] A Haines,et al. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1. , 2004, Breast.
[3] Peter J. Park,et al. A multivariate approach for integrating genome-wide expression data and biological knowledge , 2006, Bioinform..
[4] Susumu Goto,et al. The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..
[5] Qi Liu,et al. Improving gene set analysis of microarray data by SAM-GS , 2007, BMC Bioinformatics.
[6] Steven C. Lawlor,et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.
[7] R. Espinosa,et al. Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] Hanno Steen,et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.
[9] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[10] Peter Bühlmann,et al. Analyzing gene expression data in terms of gene sets: methodological issues , 2007, Bioinform..
[11] I. Ellis,et al. A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.
[12] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[13] D. Aebersold,et al. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? , 2004, Breast Cancer Research.
[14] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[15] E. Seregni,et al. Circulating tumour markers in breast cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[16] Nikolaos Kavantzas,et al. Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type. , 2003, Breast.
[17] George C Tseng,et al. Tight Clustering: A Resampling‐Based Approach for Identifying Stable and Tight Patterns in Data , 2005, Biometrics.
[18] P. V. van Diest,et al. Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma , 2003, Cancer.
[19] Hongyu Zhao,et al. Pathway analysis using random forests classification and regression , 2006, Bioinform..
[20] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Achim Zeileis,et al. Bias in random forest variable importance measures: Illustrations, sources and a solution , 2007, BMC Bioinformatics.
[23] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[24] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] I. Ellis,et al. A consensus prognostic gene expression classifier for ER positive breast cancer , 2006, Genome Biology.
[26] Arnold D K Hill,et al. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. , 2004, The Journal of clinical endocrinology and metabolism.
[27] Graham A Colditz,et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.
[28] G. Landes,et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.
[29] E. Williamson,et al. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1 , 2006, Oncogene.
[30] Javier A Menendez,et al. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? , 2006, Endocrinology.
[31] Robert Barouki,et al. BRCA1 Modulates Xenobiotic Stress-inducible Gene Expression by Interacting with ARNT in Human Breast Cancer Cells* , 2006, Journal of Biological Chemistry.
[32] Hanoch Kashtan,et al. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery. , 2003, The Israel Medical Association journal : IMAJ.
[33] D. Berry,et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. , 2006, JAMA.
[34] M. Morrow,et al. Expression of Epithelial Mucins MUC1, MUC2, and MUC3 in Ductal Carcinoma In Situ of the Breast , 2001, The breast journal.
[35] Tiffani J. Bright,et al. PubMatrix: a tool for multiplex literature mining , 2003, BMC Bioinformatics.